Company intelligence / Profile preview

Biobeat

Petach Tikva, Center, Israelbio-beat.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biobeat has developed and commercialized FDA-cleared and CE-marked wearable medical devices for continuous, cuff-less blood pressure and multi-vital sign monitoring. Their platform is used in hospitals and remote care settings to improve hypertension diagnosis/management and overall patient outcomes. Clinical results support the accuracy of their proprietary PPG-based sensors for real-time health data collection.

Therapeutic areas: OtherCardiovascular
Modalities: DeviceNon-pharmacological therapyArtificial intelligence (for data analytics)
Industry: Physiological Monitoring

Partnerships

Nuvance HealthTampa General HospitalNorthwell HealthDiscovery Limited insurance groupARC Innovation at Sheba Medical Center

Beyond the preview

Go deeper on Biobeat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biobeat.

Explore the full profile